These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 11159715

  • 1. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
    Ross RA, Gibson TM, Brockie HC, Leslie M, Pashmi G, Craib SJ, Di Marzo V, Pertwee RG.
    Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715
    [Abstract] [Full Text] [Related]

  • 2. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
    Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA, Pertwee RG.
    Br J Pharmacol; 2005 Dec; 146(7):917-26. PubMed ID: 16205722
    [Abstract] [Full Text] [Related]

  • 3. Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.
    Brooks JW, Pryce G, Bisogno T, Jaggar SI, Hankey DJ, Brown P, Bridges D, Ledent C, Bifulco M, Rice AS, Di Marzo V, Baker D.
    Eur J Pharmacol; 2002 Mar 29; 439(1-3):83-92. PubMed ID: 11937096
    [Abstract] [Full Text] [Related]

  • 4. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries.
    Vanheel B, Van de Voorde J.
    J Pharmacol Exp Ther; 2001 Feb 29; 296(2):322-8. PubMed ID: 11160613
    [Abstract] [Full Text] [Related]

  • 5. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.
    Jerman JC, Gray J, Brough SJ, Ooi L, Owen D, Davis JB, Smart D.
    Br J Anaesth; 2002 Dec 29; 89(6):882-7. PubMed ID: 12453933
    [Abstract] [Full Text] [Related]

  • 6. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats.
    del Carmen García M, Adler-Graschinsky E, Celuch SM.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct 29; 368(4):270-6. PubMed ID: 14504685
    [Abstract] [Full Text] [Related]

  • 7. A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus.
    Craib SJ, Ellington HC, Pertwee RG, Ross RA.
    Br J Pharmacol; 2001 Sep 29; 134(1):30-7. PubMed ID: 11522594
    [Abstract] [Full Text] [Related]

  • 8. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels.
    Grainger J, Boachie-Ansah G.
    Br J Pharmacol; 2001 Nov 29; 134(5):1003-12. PubMed ID: 11682448
    [Abstract] [Full Text] [Related]

  • 9. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.
    Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, Martin BR.
    Biochem Biophys Res Commun; 2001 Feb 23; 281(2):444-51. PubMed ID: 11181068
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
    Breivogel CS, Griffin G, Di Marzo V, Martin BR.
    Mol Pharmacol; 2001 Jul 23; 60(1):155-63. PubMed ID: 11408610
    [Abstract] [Full Text] [Related]

  • 11. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.
    Ahluwalia J, Urban L, Bevan S, Nagy I.
    Eur J Neurosci; 2003 Jun 23; 17(12):2611-8. PubMed ID: 12823468
    [Abstract] [Full Text] [Related]

  • 12. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
    Lay L, Angus JA, Wright CE.
    Eur J Pharmacol; 2000 Mar 10; 391(1-2):151-61. PubMed ID: 10720647
    [Abstract] [Full Text] [Related]

  • 13. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
    Ralevic V, Kendall DA, Jerman JC, Middlemiss DN, Smart D.
    Eur J Pharmacol; 2001 Jul 27; 424(3):211-9. PubMed ID: 11672565
    [Abstract] [Full Text] [Related]

  • 14. R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors.
    Nieri P, Martinotti E, Testai L, Adinolfi B, Calderone V, Breschi MC.
    Eur J Pharmacol; 2003 Jan 10; 459(1):75-81. PubMed ID: 12505536
    [Abstract] [Full Text] [Related]

  • 15. Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens.
    Pertwee RG, Thomas A, Stevenson LA, Maor Y, Mechoulam R.
    Neuropharmacology; 2005 Jun 10; 48(8):1139-46. PubMed ID: 15910889
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors.
    Mang CF, Erbelding D, Kilbinger H.
    Br J Pharmacol; 2001 Sep 10; 134(1):161-7. PubMed ID: 11522608
    [Abstract] [Full Text] [Related]

  • 17. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
    De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V.
    FEBS Lett; 2000 Oct 13; 483(1):52-6. PubMed ID: 11033355
    [Abstract] [Full Text] [Related]

  • 18. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
    Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB, Fernandez-Ruiz JJ.
    Eur J Pharmacol; 2001 May 25; 420(2-3):123-31. PubMed ID: 11408034
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
    Yousif MH, Oriowo MA.
    Pharmacol Res; 1999 Nov 25; 40(5):415-21. PubMed ID: 10527656
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological analysis of cannabinoid receptor activity in the rat vas deferens.
    Christopoulos A, Coles P, Lay L, Lew MJ, Angus JA.
    Br J Pharmacol; 2001 Mar 25; 132(6):1281-91. PubMed ID: 11250879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.